I felt like I’d stumbled upon an invisible, secret universe … and I was hooked.
Curiosity about cannabinoids drew me in a couple of years ago.
I was curious for a reason; hoping for a cure, looking for treatment, and praying for a way to prevent symptoms that can make life miserable, or worse.
As I tripped down the rabbit hole, I wasn’t even sure what I was looking for. I was about to give up, and then I found a thread to pull on.
I felt like I’d stumbled upon an invisible, secret universe.
And it seemed like a time warp.
Obscure scientific papers from the 1970s… chickens with epilepsy, cannabis tea …
I kept finding the most fascinating studies; obscure scientific papers from the 1970s, 80s and 90s.
Scientific experiments on chickens with epilepsy.
Mice with deleted cannabinoid receptors.
Cannabis tea that improved night vision.
Cancer cells destroyed when treated with THC.
I was hooked. I must’ve read 50 papers covering a 50 year period.
In 2017, I discovered an article in the New England Journal of Medicine. Children with rare forms of severe epilepsy were seeing a dramatic reduction in the number of seizures per day when CBD was added to their medicine.
Little did I know that the CBD used in those clinical trials would become the first federally approved cannabinoid drug in the FDA’s 114-year history.
Today, I can barely keep up with all of the research and clinical trials being done around the world.
It’s remarkable how far we’ve come, but it has taken a long time to get here.
As we now find ourselves struggling through the worst pandemic in a century, treatments and vaccines for COVID-19 are being developed at breathtaking speed.
Clinical trials are being fast-tracked at a pace we’ve never seen.
Experimental research is practically racing out of labs and into hospitals.
It’s all anyone talks about. And no wonder. Hundreds of millions of lives are at stake
Cannabinoid research has slipped below the radar… but 300+ clinical trials have been either completed or are underway.
It’s not surprising that cannabinoid research has slipped below the radar once again. But this time, more than 300 clinical trials have been either completed or are underway.
That means new cannabinoids-based medicine may be just around the corner.
I’ll be watching for it.